Galera Therapeutics Inc (GRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,606 | 149,049 | -4,055 | -2,667 | -1,592 |
| Accounts payable and accrued liabilities | 434 | -1,010 | -841 | -1,073 | -531 |
| Other Working Capital | 653 | -665 | -420 | -960 | -489 |
| Other Operating Activity | -356 | -153,423 | 865 | 1,006 | 374 |
| Operating Cash Flow | $-875 | $-6,049 | $-4,451 | $-3,694 | $-2,238 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 3,500 | 0 | 0 | 0 |
| Investing Cash Flow | $N/A | $3,500 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 635 | 635 | 635 | 635 |
| Financing Cash Flow | $N/A | $635 | $635 | $635 | $635 |
| Beginning Cash Position | 6,375 | 8,289 | 8,289 | 8,289 | 8,289 |
| End Cash Position | 5,500 | 6,375 | 4,473 | 5,230 | 6,686 |
| Net Cash Flow | $-875 | $-1,914 | $-3,816 | $-3,059 | $-1,603 |
| Free Cash Flow | |||||
| Operating Cash Flow | -875 | -6,049 | -4,451 | -3,694 | -2,238 |
| Free Cash Flow | -875 | -6,049 | -4,451 | -3,694 | -2,238 |